Glaxo Wellcome:

Operating from 76 different countries, the company’s extensive drug portfolio includes the ulcer blockbuster Zantac and the asthma inhaler Ventolin. Glaxo Wellcome is about to launch two new products: Ziagen, a new anti-HIV treatment, and its latest asthma drug, Flixotide.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article

Registration includes the following benefits:

  • Access up to four FREE articles per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.

Registered users and subscribers SIGN IN here to continue